Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Issues Guidance On Off-Label Info; Waxman Seeks ‘Re-examination’

This article was originally published in The Pink Sheet Daily

Executive Summary

The guidance supports long-standing policy on scientifically sound journal articles and imparts no new freedoms, device industry organization AdvaMed says.

You may also be interested in...



AdvaMed Seeks More Safeguards For Distributing Off-Label Journal Articles

The device industry wants more protection than that supplied in draft FDA guidance on appropriate dissemination of journal articles for studies of non-approved product uses, while some members of Congress believe distribution of off-label study information should be banned outright

Waxman Asks FDA Not To Issue Guidance On Off-Label Promotion

Rep. Henry Waxman, chair of the House Committee on Oversight and Government Reform, is urging FDA not to go forward with a guidance that he says would allow companies to use journal articles to promote off-label uses of devices and drugs

FDA Needs Information Technology Strategic Plan, GAO Recommends

FDA has at least 16 projects under way to improve its information technology systems and infrastructure, but no comprehensive IT strategic plan to coordinate and manage the efforts, according to the Government Accountability Office

Topics

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel